Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells.

Street, D; Kaufmann, A M; Vaughan, A; Fisher, S G; Hunter, M; Schreckenberger, C; Potkul, R K; Gissmann, L; Qiao, L

Street, D; Kaufmann, A M; Vaughan, A; Fisher, S G; Hunter, M; Schreckenberger, C; Potkul, R K; Gissmann, L; Qiao, L.

Affiliation

Street D; Department of Obstetrics and Gynecology, Stritch School of Medicine, Loyola University Medical Center, Maywood, Illinois 60153, USA.

Gynecol Oncol ; 65(2): 265-72, 1997 May.

Article in En | MEDLINE | ID: mdl-9159336

Subject(s)

Interferon-gamma/therapeutic use; T-Lymphocytes, Cytotoxic/immunology; Uterine Cervical Neoplasms/immunology; Uterine Cervical Neoplasms/therapy; B7-1 Antigen/biosynthesis; B7-1 Antigen/immunology; CD58 Antigens/biosynthesis; CD58 Antigens/immunology; Female; Gene Expression Regulation, Neoplastic; Humans; Intercellular Adhesion Molecule-1/biosynthesis; Intercellular Adhesion Molecule-1/immunology; Major Histocompatibility Complex/genetics; Major Histocompatibility Complex/immunology; Tumor Cells, Cultured; Up-Regulation; Uterine Cervical Neoplasms/pathology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / Uterine Cervical Neoplasms / Interferon-gamma Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 1997 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links